Scholar Rock has received reports of scammers posting fake jobs using Scholar Rock’s name or making fraudulent job offers in Scholar Rock’s name. We have contacted several job boards to get fraudulent job postings removed. If you see a job that is supposedly advertised by Scholar Rock, please check its validity by visiting our website and applying directly at our careers page, where we’ve also added some tips on how to protect yourself from those scams. Visit: https://lnkd.in/eNqC_PX
Scholar Rock
Biotechnology
Cambridge, Massachusetts 7,443 followers
Scholar Rock is a biopharmaceutical company that discovers, develops and delivers life-changing therapies
About us
Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at ScholarRock.com and follow @ScholarRock and on LinkedIn. For additional information on our guidelines, please visit https://scholarrock.com/community-guidelines/ For more information on how Scholar Rock collects, uses, and shares personal information, please visit: https://scholarrock.com/privacy-policy/
- Website
-
https://scholarrock.com
External link for Scholar Rock
- Industry
- Biotechnology
- Company size
- 51-200 employees
- Headquarters
- Cambridge, Massachusetts
- Type
- Public Company
- Founded
- 2012
Locations
-
Primary
Get directions
301 Binney St
Cambridge, Massachusetts 02142, US
Employees at Scholar Rock
-
Peter McLaughlin
VP of IT at Scholar Rock
-
Kerry Costello
Vice President @ Scholar Rock | Program Leadership, Strategy
-
Jing Marantz, MD PhD
Physician-Scientist | CMO | Board Member
-
Jim Zhang
Head of Regulatory Operations | Building sustainable and scalable Reg Ops infrastructure for biotech startup and small pharmaceuticals
Updates
-
Yesterday at #ADA2024, Scholar Rock shared preclinical data from our SRK-439 program in #obesity highlighting the potential of our investigational myostatin inhibitor to promote healthy body composition during GLP-1 receptor agonist-induced weight loss. Learn more: https://bit.ly/4c8Iz9k
Scholar Rock Announces New SRK-439 Preclinical Data Showing Significant Lean Mass Preservation and Attenuation of Fat Mass Rebound Following GLP-1 Receptor Agonist Withdrawal | Scholar Rock, Inc.
investors.scholarrock.com
-
Next week, Scholar Rock will present recent preclinical data from our SRK-439 program in #obesity at the American Diabetes Association 84th Scientific Sessions. #ADA2024
-
-
Our team had such an insightful and rewarding experience at the #2024SMAConference last week. We’re grateful for this annual opportunity to connect with the SMA community. Thank you to Cure SMA for bringing us together to learn, collaborate and champion what matters most to those living with #SMA.
-
-
This evening, our Scholar Rock colleagues will present a family-friendly poster at the #2024SMAConference highlighting the role of muscle in SMA and the progress we've made with our investigational treatment for #SMA.
-
-
If you’re at the #2024SMAConference, stop by the Muscle Station at Booth 8 on Friday and Saturday to learn more about why muscle matters for people living with SMA. The booth will be giving away refreshments and hosting presentations by an SMA physical therapist.
-
-
Thank you to the patient advocates and healthcare providers who attended Scholar Rock’s reception yesterday evening. We had a great time connecting with you all and look forward to seeing you at the Cure SMA #2024SMAConference this week!
-
-
At Scholar Rock, we understand that muscle matters and have launched a first-ever hub dedicated to muscle in SMA. This hub emphasizes a remaining unmet need for people living with #SMA: sustaining and gaining muscle strength. Visit LifeTakesMuscle.com to learn more from patient advocates and healthcare providers about the impact of progressive muscle weakness for individuals living with SMA. Intended for US residents and HCPs.
-
This week, Scholar Rock shared new SRK-181 data from our Phase 1 DRAGON proof-of-concept trial at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. These new data provide further evidence of SRK-181’s potential to overcome resistance to immune checkpoint inhibitors and validate the selective approach of our TGFβ platform. Visit our website to learn more: https://bit.ly/3yIViRb #ASCO24
Scholar Rock Presents New Data from SRK-181 Phase 1 DRAGON Trial at ASCO 2024 Annual Meeting | Scholar Rock, Inc.
investors.scholarrock.com
-
Scholar Rock is proud to be a Title Sponsor of the Cure SMA 2024 Annual SMA Conference and the Annual SMA Research & Clinical Care Meeting. We look forward to seeing the #SMA community this week in Austin! #2024SMAConference
Thank you to Scholar Rock for partnering with Cure SMA as a Title Exhibitor of the 2024 Annual SMA Conference!
-